银杏新制剂治疗缺血性脑卒中恢复期30例

目的观察银杏二萜内酯葡胺注射液治疗缺血性脑卒中(痰瘀阻络证)的疗效及安全性。方法将我科室60例脑卒中恢复期患者随机分为治疗组和对照组各30例,治疗组采用银杏二萜内酯葡胺注射液静脉滴注,对照组采用丹参芎嗪注射液静脉滴注,疗程均为14 d。比较两组临床疗效。结果两组临床疗效间差异有统计学意义(u=2.238,P=0.012)。结论银杏二萜内酯葡胺注射液治疗缺血性脑卒中安全有效,值得在临床上推广使用。

New Preparations of Ginkgo Biloba in the Thetreatment of Ischemic Stroke at Convalescent Stage for 30 Cases

Objective To observe the therapeutic effect and safety of diterpene lactones of Ginkgo biloba meglumine injection in the treatment of ischemic stroke ( phlegm and blood stasis syndrome ) .Methods 60 cases of patients with stroke at recovery period in our department were randomly divided into treatment group and control group , with 30 cases in each group .The treatment group used diterpene lactones of Ginkgo biloba meglumine injection for intravenous injection .The control group was treated with Salvia miltiorrhiza Ligusticum chuanxiong injection for intravenous drip .The course of treatment was 14 days.The clinical effect of the two groups was compared .Results There were significant differences in clinical effect between the two groups (U=2.238, P=0.012).Conclusion The diterpene lactones of Ginkgo biloba meglumine injection in the treatment of ischemic stroke is safe and effective , and it is worthy to be popularized in clinic .